Description
Glyxambi Tablet (Empagliflozin + Linagliptin) – Treatment for Type 2 Diabetes Mellitus
Glyxambi Tablet is an innovative combination medication containing Empagliflozin and Linagliptin, designed to effectively manage Type 2 Diabetes Mellitus in adults. This dual-action formula works synergistically with diet and exercise to improve blood sugar control by enhancing insulin utilization and eliminating excess glucose through urine. Unlike single-mechanism antidiabetics, Glyxambi addresses multiple pathways of glucose regulation, reducing risks of severe diabetes complications like kidney damage and vision problems. The convenient once-daily dosage can be taken with or without food, though consistency in timing is recommended for optimal results. As part of a comprehensive treatment plan, Glyxambi should be combined with lifestyle modifications including healthy eating and regular physical activity for maximum therapeutic benefit.
Uses of Glyxambi Tablet:
Benefits of Glyxambi Tablet:
- Dual-action formula targets multiple glucose regulation pathways
- Promotes urinary glucose excretion
- Reduces liver glucose production
- Enhances insulin sensitivity
- Convenient once-daily dosing
Side Effects of Glyxambi Tablet:
- Urinary tract infections
- Nasopharyngitis (throat/nasal inflammation)
- Genital fungal infections
- Hypoglycemia (when combined with other antidiabetics)
- Cough
- Nausea/vomiting
- Constipation
How to Use Glyxambi Tablet?
Take Glyxambi Tablet once daily, with or without food, as prescribed by your doctor. Swallow the tablet whole with water—do not crush, chew, or break it. For best results, maintain a consistent dosing schedule. Continue taking even if you feel well, as diabetes requires ongoing management.
How Glyxambi Tablet Works?
Glyxambi combines two antidiabetic agents: Empagliflozin (SGLT2 inhibitor) promotes glucose excretion through urine, while Linagliptin (DPP-4 inhibitor) reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin secretion. This dual mechanism provides comprehensive blood sugar control.
Safety Advice:
- Alcohol: Unsafe—increases hypoglycemia and dehydration risk
- Pregnancy: Contraindicated—potential fetal harm
- Breastfeeding: Avoid—may pass into breastmilk
- Driving: Caution—may affect alertness if hypoglycemia occurs
- Kidney: Contraindicated in severe disease/dialysis
- Liver: Safe in mild-to-moderate disease; avoid in severe impairment
What If You Miss a Dose?
Take the missed dose as soon as remembered, unless it’s nearly time for the next dose. Never double the dose to compensate. Maintain regular monitoring of blood sugar levels if a dose is missed.
FAQs:
Q1. What is Glyxambi Tablet and how does it work?
Glyxambi combines Empagliflozin (removes excess glucose via urine) and Linagliptin (reduces liver glucose production and enhances insulin). Together they provide comprehensive blood sugar control.
Q2. Who should take Glyxambi Tablet?
Adults with Type 2 Diabetes when diet/exercise alone are insufficient. Particularly beneficial for those with cardiovascular disease to reduce complication risks.
Q3. How should I take Glyxambi Tablet?
Take once daily, with/without food, at a consistent time. Never stop without medical advice.
Q4. Can Glyxambi be used for Type 1 diabetes?
No—it’s contraindicated for Type 1 diabetes or diabetic ketoacidosis.
Q5. Does Glyxambi cause hypoglycemia?
Rare when used alone, but risk increases with insulin/sulfonylureas. Regular glucose monitoring is essential.
Q6. Is Glyxambi safe during pregnancy/breastfeeding?
No—alternative treatments should be considered. Consult your doctor.
Q7. What precautions should I take with Glyxambi?
Avoid alcohol, stay hydrated, and practice good hygiene to prevent genital infections.
Q8. Can Glyxambi help with weight loss?
Empagliflozin may cause mild weight loss through glucose excretion, but this isn’t its primary purpose.
Q9. How should Glyxambi be stored?
Store at room temperature (15-30°C), protected from moisture and light. Keep away from children.
There are no reviews yet.